Aprea Therapeutics Inc. Stock News

Aprea Therapeutics Inc., (APRE), a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein, today a

SEBI regulations already permit REIT, InvITs' debt issuance to foreign portfolio investors. Finance Minister Nirmala Sitharaman, in Union Budget 2019, had already allowed foreign portfolio investors (

ZenWTR expects to keep up to 70 million PET water bottles from reaching the ocean in 2020.

The Consumer Financial Protection Bureau plans to change the definition of what constitutes a qualified mortgage from a 43% debt-to-income limit to a price-based threshold, and further extend a tempor

Buying a home is one of the most exciting things you’ll do in your life. It’s also likely the most expensive. Unless you have a swimming pool full of cash, you’ll need to take out a mortgage to

If you’re looking to pay off one credit balance using another card, this generally isn’t possible. Banks don’t allow you to pay your credit card balance using another credit card. Typically, pay

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fate Therapeutics (FATE – Research

CNBC Select shares how high the average debt consolidation and credit card refinancing loans were in early 2020 and explains how a personal loan can save you money.

Your interest rate isn't the only important factor when refinancing.

Staking is a quickly gaining popularity in the world of cryptocurrency, as the process of earning a profit while helping to secure the underlying network is an attractive proposition. After all, by st

Aprea Therapeutics (NASDAQ:APRE) Director Scott M. Rocklage sold 245,000 shares of the business’s stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $28.75,